Unity Biotechnology, Inc. Depreciation
Unity Biotechnology, Inc. reported Depreciation of $900.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-03-07
- Unity Biotechnology, Inc. depreciation for fiscal 2024 was $900.00K, a 25.00% decline from fiscal 2023.
- Unity Biotechnology, Inc. depreciation for fiscal 2023 was $1.20M, a 45.45% decline from fiscal 2022.
- Unity Biotechnology, Inc. depreciation for fiscal 2022 was $2.20M, a 24.14% decline from fiscal 2021.
- Unity Biotechnology, Inc. depreciation for fiscal 2021 was $2.90M, a 14.71% decline from fiscal 2020.
| Period end | Depreciation 12 month |
|---|---|
| 2024-12-31 | $900.00K 10-K · filed 2025-03-07 |
| 2023-12-31 | $1.20M 10-K · filed 2025-03-07 |
| 2022-12-31 | $2.20M 10-K · filed 2025-03-07 |
| 2021-12-31 | $2.90M 10-K · filed 2024-04-15 |
| 2020-12-31 | $3.40M 10-K · filed 2023-03-15 |
| 2019-12-31 | $2.70M 10-K · filed 2022-03-15 |
| 2018-12-31 | $2.20M 10-K · filed 2021-03-23 |
| 2017-12-31 | $1.30M 10-K · filed 2020-03-11 |
| 2016-12-31 | $200.00K 10-K · filed 2019-03-06 |